Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

PMGM

Priveterra Acquisition Corp. II

Last Close
May 07 • 04:00PM ET
11.05
Dollar change
-0.17
Percentage change
-1.52 		%
Scroll to Statements
Index- P/E129.54 EPS (ttm)0.09 Insider Own78.21% Shs Outstand8.82M Perf Week0.00%
Market Cap97.46M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.92M Perf Month0.00%
Income1.00M PEG- EPS next Q- Inst Own20.65% Short Float0.03% Perf Quarter3.08%
Sales0.00M P/S- EPS this Y- Inst Trans17.87% Short Ratio1.03 Perf Half Y6.71%
Book/sh0.70 P/B15.70 EPS next Y- ROA0.67% Short Interest0.00M Perf Year10.94%
Cash/sh0.00 P/C2436.53 EPS next 5Y- ROE0.74% 52W Range10.42 - 11.22 Perf YTD0.55%
Dividend Est.- P/FCF- EPS past 5Y- ROI16.18% 52W High-1.52% Beta0.01
Dividend TTM- Quick Ratio0.02 Sales past 5Y- Gross Margin- 52W Low6.05% ATR (14)0.08
Dividend Ex-Date- Current Ratio0.02 EPS Y/Y TTM-74.54% Oper. Margin0.00% RSI (14)52.11 Volatility0.02% 0.06%
Employees- Debt/Eq0.10 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-800.90% Payout- Rel Volume0.02 Prev Close11.22
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume0.63K Price11.05
SMA200.10% SMA501.04% SMA2004.97% Trades Volume13 Change-1.52%
May-03-24 05:30PM
Priveterra Acquisition Corp. II Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
(Business Wire)
Jul-24-23 07:00AM
AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update
(GlobeNewswire)
Jul-21-23 04:27PM
Priveterra Acquisition Corp. Announces Completion of Business Combination with AEON Biopharma, Inc.
(Business Wire)
Jul-17-23 05:02PM
Priveterra Acquisition Corp. Announces Authorization to List on NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.
(Business Wire)
Jul-11-23 06:40PM
Priveterra Acquisition Corp. Announces Intention to Transfer to NYSE Upon Completion of Business Combination with AEON Biopharma, Inc.
(Business Wire)
08:00AM Loading…
Jun-30-23 08:00AM
AEON Biopharma and Priveterra Announce Arrangement of Up to $125 Million of Financing in Connection with Proposed Business Combination
(GlobeNewswire)
Priveterra Acquisition Corp. II is a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on August 10, 2020 and is headquartered in Irvine, CA.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.